Dosage & Administration
Adults: Apply externally twice daily to properly cleaned & dried affected portion.
Children under 18 years: Please consult physician.
Osteodin-z
FDA Label NDC 69825-003
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Adven Biotech Private Limited for the product Osteodin-z (NDC 69825-003). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding dosage & administration, warnings, inactive ingredient, otc - purpose, otc - active ingredient, indications & usage, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Warnings
If symptons persist or worsen, a physician should be consulted. Keep out of reach of children. Do not use, if known sentivity to any of its ingredients exists. In case of emergency, contact a medical professional or posion control center immediately. For external use only. Replace cap tightly.
Inactive Ingredient
Vaseline base
Otc - Purpose
Relieves arthritis pain
Relieves joint pain
Relieves pain
Otc - Active Ingredient
Rhus toxicondendron, Hypericum perforatum, Ruta graveolens, Bellis pernnis, Menthol
Indications & Usage
For the relief of joins pain, ligaments & tendons pain, Rheumatic pain, Sciatica, Neuralgia, Cramps in calves, Sprains, Muscular soreness.
Package Label.Principal Display Panel
Osteodin Z Ointment (Osteodinzointment)
* Please review the disclaimer below.
